Increased functional capacity after 12 weeks of exercise training does not transform into improved skeletal muscle metabolism or ultrastructure in heart failure patients on modern optimal medical therapy

Drexler H Riede U Munzel T , et al. Alterations of skeletal muscle in chronic heart failure. Circulation 85: 1751–1759.

Hambrecht R Fiehn E Yu J , et al. Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol 1997; 29: 1067–1073.

Ellingsen Ø Halle M Conraads VM , et al. High intensity interval training in heart failure patients with reduced ejection fraction. Circulation 2017; 135: 839–849.

Valborgland T Isaksen K Munk PS , et al. Impact of an exercise training program on cardiac neuronal function in heart failure patients on optimal medical therapy: a randomized Iodine-123 metaiodobenzylguanidine scintigraphy study. J Nucl Cardiol. Epub ahead of print 17 January 2017. DOI: 10.1007/s12350-016-0724-8.

Larsen AI Lindal S Aukrust PP , et al. Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity. Int J Cardiol 83: 25–32.

Dalla Libera L Ravara B Gobbo V , et al. Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of Carvedilol. J Mol Cell Cardiol 38: 803–807.

Clark AL Coats AJ Krum H , et al. Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial. J Cachexia Sarcopenia Muscle 18: 259.

Pitt B Zannad F Remme WJ , et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341: 709–717.

Pitt B Remme W Zannad F , et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348: 1309–1321.

Chadwick JA Hauck JS Lowe J , et al. Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target. FASEB J 29: 4544–4554.

Rafael-Fortney JA Chimanji NS Schill KE , et al. Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice. Circulation 124: 582–588.

Breitenbach S Lehmann-Horn F Jurkat-Rott K. Eplerenone repolarizes muscle membrane through Na,K-ATPase activation by Tyr10 dephosphorylation. Acta Myol 35: 86–89.

Zannad F Alla F Dousset B , et al. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 102: 2700–2706.

Natali PG Bigotti A Nicotra MR , et al. Distribution of human class I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res 44: 4679–4687.

Needham M Fabian V Knezevic W , et al. Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscular Disorders 2007; 17: 194–200.

Liang C Needham M. Necrotizing autoimmune myopathy. Curr Opin Rheumatol 23: 612–619.

Tzanis G Philippou A Karatzanos E , et al. Effects of high-intensity interval exercise training on skeletal myopathy of chronic heart failure. J Card Fail 2017; 23: 36–46.

Tyni-Lenné R Jansson E Sylvén C. Female-related skeletal muscle phenotype in patients with moderate chronic heart failure before and after dynamic exercise training. Cardiovasc Res 42: 99–103.

Gustafsson T Bodin K Sylvén C , et al. Increased expression of VEGF following exercise training in patients with heart failure. Eur J Clin Invest 31: 362–366.

Kiilavuori K Näveri H Salmi T , et al. The effect of physical training on skeletal muscle in patients with chronic heart failure. Eur J Heart Fail 2: 53–63.

Harjola V-P Kiilavuori K Virkamäki A. The effect of moderate exercise training on skeletal muscle myosin heavy chain distribution in chronic heart failure. Int J Cardiol 109: 335–338.

Gielen S Adams V Linke A , et al. Exercise training in chronic heart failure: correlation between reduced local inflammation and improved oxidative capacity in the skeletal muscle. Eur J Cardiovasc Prev Rehabil 12: 393–400.

Wisløff U Stoylen A Loennechen JP , et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115: 3086–3094.

Tyni-Lenné R Gordon A Jansson E , et al. Skeletal muscle endurance training improves peripheral oxidative capacity, exercise tolerance, and health-related quality of life in women with chronic congestive heart failure secondary to either ischemic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol 1997; 80: 1025–1029.

Duscha BD Kraus W Keteyian SJ , et al. Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol 33: 1956–1963.

Vescovo G Dalla Libera L Serafini F , et al. Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition. Circulation 98: 1742–1749.

Murrow JR Brizendine JT Djire B , et al. Near infrared spectroscopy-guided exercise training for claudication in peripheral arterial disease. Eur J Prev Cardiol 26: 471–480.

Munzel T Kurz S Drexler H. Are alterations of skeletal muscle ultrastructure in patients with heart failure reversible under treatment with ACE-inhibitors? Herz 18 (Suppl. 1): 400–405.